Oxidative stress pathway genes and chronic renal insufficiency in Asian Indians with Type 2 diabetes

Journal of Diabetes and its Complications

Volumn 23, Issue 2, 2009, Pages 102-111

  Tiwari, Arun K ^a   Prasad, Pushplata ^a   B K , Thelma ^a   Kumar, K M Prasanna ^b   Ammini, A C ^c   Gupta, Arvind ^d   Gupta, Rajeev ^e  

^a UNIVERSITY OF DELHI   (India)

^b M S RAMAIAH MEDICAL COLLEGE   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d Jaipur Engineering College and Research Centre   (India)

^e Monilek Hospital   (India)

Author keywords

Association; Candidate genes; Chronic renal insufficiency; India; Oxidative stress; Single nucleotide polymorphisms

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2; COPPER ZINC SUPEROXIDE DISMUTASE; CREATININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; IRON SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCOUPLING PROTEIN 1; UNCOUPLING PROTEIN 2; VASCULOTROPIN;

ADULT; ALLELE; ARTICLE; ASIAN; CHRONIC KIDNEY FAILURE; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENAL PROTECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SURVIVAL; WILD TYPE;

ARYLDIALKYLPHOSPHATASE; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DNA; GLUTATHIONE TRANSFERASE; HUMANS; INDIA; KIDNEY FAILURE, CHRONIC; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SUPEROXIDE DISMUTASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 59849091791     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2007.10.003     Document Type: Article

References (53)

1. American Diabetes Association. Diabetic nephropathy. Diabetes Care 25 (2002) S85-S89
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
3. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 54 (2005) 1615-1625
4. Basu A., Mukherjee N., Roy S., Sengupta S., Banerjee S., Chakraborty M., Dey B., Roy M., Roy B., Bhattacharyya N.P., Roychoudhury S., and Majumder P.P. Ethnic India: A genomic view, with special reference to peopling and structure. Genome Research 13 (2003) 2277-2290
5. Chistyakov D.A., Savost'anov K.V., Zotova E.V., and Nosikov V.V. Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus. BMC Medical Genetics 2 (2001) 4
6. Czekalski S. Diabetic nephropathy and cardiovascular diseases. Roczniki Akademii Medycznej w Bialymstoku 50 (2005) 122-125
7. Doney A.S., Lee S., Leese G.P., Morris A.D., and Palmer C.N. Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: A Go-DARTS study. Circulation 111 (2005) 2927-2934
8. Earle K.K., Porter K.A., Ostberg J., and Yudkin J.S. Variation in the progression of diabetic nephropathy according to racial origin. Nephrology, Dialysis, Transplantation 16 (2001) 286-290
9. Esterbauer H., Schneitler C., Oberkofler H., Ebenbichler C., Paulweber B., Sandhofer F., Ladurner G., Hell E., Strosberg A.D., Patsch J.R., Krempler F., and Patsch W. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nature Genetics 28 (2001) 178-183
10. Fujita H., Narita T., Meguro H., Ishii T., Hanyu O., Suzuki K., Kamoi K., and Ito S. Lack of association between an ecNOS gene polymorphism and diabetic nephropathy in type 2 diabetic patients with proliferative diabetic retinopathy. Hormone and Metabolic Research 32 (2000) 80-83
11. Fujita H., Narita T., Meguro H., Shimotomai T., Kitazato H., Kagaya E., Sugasawa H., Hanyu O., Suzuki K., and Ito S. No association of glutathione S-transferase M1 gene polymorphism with diabetic nephropathy in Japanese type 2 diabetic patients. Renal Failure 22 (2000) 479-486
12. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine 351 (2004) 1296-1305
13. Gross J.L., de Azevedo M.J., Silveiro S.P., Canani L.H., Caramori M.L., and Zelmanovitz T. Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care 28 (2005) 164-176
14. Gupta R., and Misra A. Type-2 diabetes epidemiology in India: Focus on regional disparities. British Journal of Diabetes Vascular Diseases 7 (2007) 12-16
15. Hayden M.R., Whaley-Connell A., and Sowers J.R. Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: Paying homage to the podocyte. American Journal of Nephrology 25 (2005) 553-569
16. Herrmann S.M., Wang J.G., Staessen J.A., Kertmen E., Schmidt-Petersen K., Zidek W., Paul M., and Brand E. Uncoupling protein 1 and 3 polymorphisms are associated with waist-to-hip ratio. International Journal of Molecular Medicine 81 (2003) 327-332
17. Hu X., Xia H., Srivastava S.K., Pal A., Awasthi Y.C., Zimniak P., and Singh S.V. Catalytic efficiencies of allelic variants of human glutathione S-transferase P1-1 toward carcinogenic anti-diol epoxides of enzo[c]phenanthrene and benzo[g]chrysene. Cancer Research 58 (1998) 5340-5343
18. King G.L., and Loeken M.R. Hyperglycemia-induced oxidative stress in diabetic complications. Histochemistry and Cell Biology 122 (2004) 333-338
19. Ksiazek P., Wojewoda P., Muc K., and Buraczynska M. Endothelial nitric oxide synthase gene intron 4 polymorphism in type 2 diabetes mellitus. Molecular Diagnosis 7 (2003) 119-123
20. Leon C.A., and Raij L. Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy. Journal of Hypertension 23 (2005) 1931-1937
21. Levey A.S., Coresh J., Balk E., Kausz A.T., Levin A., Steffes M.W., Hogg R.J., Perrone R.D., Lau J., and Eknoyan G. National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Annals of Internal Medicine 139 (2003) 137-147
22. Lin C.C., Wu H.C., Tsai F.J., Chen H.Y., and Chen W.C. Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer. Urology 62 (2003) 374-377
23. Mann J.F. Cardiovascular risk in patients with mild renal insufficiency: Implications for the use of ACE inhibitors. La Presse Medicale 34 (2005) 1303-1308
24. Mann J.F., Gerstein H.C., Pogue J., Bosch J., and Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Annals of Internal Medicine 134 (2001) 629-636
25. pHOX C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. Diabetes Care 27 (2004) 303-307
26. Miyamoto Y., Saito Y., Kajiyama N., Yoshimura M., Shimasaki Y., Nakayama M., Kamitani S., Harada M., Ishikawa M., Kuwahara K., Ogawa E., Hamanaka I., Takahashi N., Kaneshige T., Teraoka H., Akamizu T., Azuma N., Yoshimasa Y., Yoshimasa T., Itoh H., Masuda I., Yasue H., and Nakao K. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32 (1998) 3-8
27. Mohan V. Indians more prone to diabetes?. Journal of the Association of Physicians of India 52 (2004) 468-474
28. Mori H., Okazawa H., Iwamoto K., Maeda E., Hashiramoto M., and Kasuga M. A polymorphism in the 5′ untranslated region and a Met229->Leu variant in exon 5 of the human UCP1 gene are associated with susceptibility to type II diabetes mellitus. Diabetologia 44 (2001) 373-376
29. Nagai N., Sakane N., Ueno L.M., Hamada T., and Moritani T. The -3826 A->G variant of the uncoupling protein-1 gene diminishes postprandial thermogenesis after a high fat meal in healthy boys. Journal of Clinical Endocrinology and Metabolism 88 (2003) 5661-5667
30. Neugebauer S., Baba T., and Watanabe T. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 49 (2000) 500-503
31. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M.A., Beebe D., Oates P.J., Hammes H.P., Giardino I., and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
32. Nomiyama T., Tanaka Y., Piao L., Nagasaka K., Sakai K., Ogihara T., Nakajima K., Watada H., and Kawamori R. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. Journal of Human Genetics 48 (2003) 138-141
33. Pinizzotto M., Castillo E., Fiaux M., Temler E., Gaillard R.C., and Ruiz J. Paraoxonase2 polymorphisms are associated with nephropathy in Type II diabetes. Diabetologia 44 (2001) 104-107
34. Renner W., Kotschan S., Hoffmann C., Obermayer-Pietsch B., and Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. Journal of Vascular Research 37 (2000) 443-448
35. Retnakaran R., Cull C.A., Thorne K.I., Adler A.I., and Holman R.R. Risk factors for renal dysfunction in type 2 diabetes: UK. Prospective diabetes study 74. Diabetes 55 (2006) 1832-1839
36. Ritz E., and Orth S.R. Nephropathy in patients with type 2 diabetes mellitus. New England Journal of Medicine 341 (1999) 1127-1133
37. Ritz E., and Stefanski A. Diabetic nephropathy in type II diabetes. American Journal of Kidney Diseases 27 (1996) 167-194
38. Rosenblum J.S., Gilula N.B., and Lerner R.A. On signal sequence polymorphisms and diseases of distribution. Proceedings of the National Academy of Sciences of the United States of America 93 (1996) 4471-4473
39. Ruggenenti P., and Remuzzi G. Nephropathy of type-2 diabetes mellitus. Journal of the American Society of Nephrology 9 (1998) 2157-2169
40. Salanti G., Amountza G., Ntzani E.E., and Ioannidis J.P. Hardy-Weinberg equilibrium in genetic association studies: An empirical evaluation of reporting, deviations, and power. European Journal of Human Genetics 13 (2005) 840-848
41. pHOX C242T polymorphism with nephropathy in type 2 diabetic patients. Journal of Nephrology 18 (2005) 733-738
42. Sham P.C., and Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Annals of Human Genetics 59 (1995) 97-105
43. Sheetz M.J., and King G.L. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. Journal of the American Medical Association 288 (2002) 2579-2588
44. Shimasaki Y., Yasue H., Yoshimura M., Nakayama M., and Kugiyama K. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. Journal of the American College of Cardiology 31 (1998) 1506-1510
45. Shimizu T., Onuma T., Kawamori R., Makita Y., and Tomino Y. Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Research and Clinical Practice 58 (2002) 179-185
46. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori Y., Shimizu Y., and Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochemical and Biophysical Research Communications 226 (1996) 561-565
47. Stephens M., and Donnelly P. Comparison of Bayesian methods for haplotype reconstruction from population genotype data. American Journal of Human Genetics 73 (2003) 1162-1169
48. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. American Journal of Human Genetics 68 (2001) 978-989
49. van Dijk C., and Berl T. Pathogenesis of diabetic nephropathy. Reviews in Endocrine and Metabolic Disorders 5 (2004) 237-248
50. Viswanatham V., Snehalatha C., Mathai T., Jayaraman M., and Ramachandran A. Cardiovascular morbidity in proteinuric south Indian NIDDM patients. Diabetes Research and Clinical Practice 39 (1998) 63-67
51. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
52. Yoshimura M., Yasue H., Nakayama M., Shimasaki Y., Sumida H., Sugiyama S., Kugiyama K., Ogawa H., Ogawa Y., Saito Y., Miyamoto Y., and Nakao K. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Human Genetics 103 (1998) 65-69
53. Young B.A., Maynard C., and Boyko E.J. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care 26 (2003) 2392-2399